NCT03427463View on ClinicalTrials.gov

Comparison of 0.1 and 0.05mg Intrathecal Morphine for Post-cesarean Analgesia.

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

January 16, 2018

Primary Completion Date

August 3, 2023

Study Completion Date

August 3, 2023

Conditions
Cesarean Section
Interventions
DRUG

receiving 0.1 mg IT morphine

Patients will receive the standard of care dose 0.1 mg of intrathecal morphine

DRUG

recieving 0.05 mg IT morphine

Patients will receive 0.05 mg of intrathecal morphine

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT03427463 - Comparison of 0.1 and 0.05mg Intrathecal Morphine for Post-cesarean Analgesia. | Biotech Hunter | Biotech Hunter